- Home
- COLL vs THRM Comparison
COLL vs THRM Comparison
Compare COLL & THRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- THRM
- Stock Information
- Founded
- COLL 2002
- THRM 1991
- Country
- COLL United States
- THRM United States
- Employees
- COLL 357
- THRM N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- THRM Auto Parts:O.E.M.
- Sector
- COLL Health Care
- THRM Consumer Discretionary
- Exchange
- COLL Nasdaq
- THRM Nasdaq
- Market Cap
- COLL 1.1B
- THRM 997.7M
- IPO Year
- COLL 2015
- THRM 1993
- Fundamental
- Price
- COLL $34.62
- THRM $36.66
- Analyst Decision
- COLL Strong Buy
- THRM Buy
- Analyst Count
- COLL 4
- THRM 3
- Target Price
- COLL $44.25
- THRM $47.67
- AVG Volume (30 Days)
- COLL 319.8K
- THRM 209.8K
- Earning Date
- COLL 11-06-2025
- THRM 10-23-2025
- Dividend Yield
- COLL N/A
- THRM N/A
- EPS Growth
- COLL N/A
- THRM N/A
- EPS
- COLL 1.06
- THRM 0.99
- Revenue
- COLL $707,007,000.00
- THRM $1,468,728,000.00
- Revenue This Year
- COLL $21.29
- THRM $1.85
- Revenue Next Year
- COLL $3.36
- THRM $2.97
- P/E Ratio
- COLL $32.88
- THRM $37.36
- Revenue Growth
- COLL 22.61
- THRM N/A
- 52 Week Low
- COLL $23.23
- THRM $22.75
- 52 Week High
- COLL $39.95
- THRM $47.00
- Technical
- Relative Strength Index (RSI)
- COLL 49.72
- THRM 58.89
- Support Level
- COLL $34.46
- THRM $36.40
- Resistance Level
- COLL $35.90
- THRM $38.19
- Average True Range (ATR)
- COLL 0.97
- THRM 1.13
- MACD
- COLL 0.19
- THRM 0.28
- Stochastic Oscillator
- COLL 69.18
- THRM 75.28
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About THRM Gentherm Inc
Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.